Sharon Marcanthony, MD
Obstetrics & Gynecology · Wooster, OHNPI 1508046012
Payments from drug & device makers
Across 34 payments — averaging $20.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$132
- AbbVie$74
- Organon$60
- BD$59
- Sage Therapeutics, LLC$58
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$38
- plus $288 from 15 others
What the payments were for
- Food & beverage$63589%
- Education$7511%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 3 | $132 |
| AbbVie(2 entities) | 5 | $74 |
| Organon | 3 | $60 |
| BD | 1 | $59 |
| Sage Therapeutics, LLC | 3 | $58 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Mylan Pharmaceuticals Inc. | 2 | $30 |
| Bayer | 1 | $23 |
| Pfizer | 1 | $23 |
| Johnson & Johnson | 1 | $20 |
| Intra-sana Laboratories | 1 | $19 |
| Mayne Pharma Commercial LLC | 1 | $19 |
| Exact Sciences | 1 | $18 |
| Myovant Sciences Inc. | 1 | $17 |
| Olympus America Inc. | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Novo Nordisk | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Avion Pharmaceuticals | 1 | $13 |
| Davol Inc. | 1 | $11 |
How this compares
$710 in reported general payments places this provider in the 50th percentile of 1,376 obstetrics & gynecology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 17 | $339 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 11 | $185 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Wooster
- Margaret RheeAkron$19.6M
- Harold GreenColumbus$2.3M
- Stuart WeprinEnglewood$1.2M
- Abner CorderoTiffin$985K
- Jeffrey MangelCleveland$886K
- Angelina GangestadCleveland$744K
- Gerard ReillyCincinnati$582K
- Sarah ArtmanHilliard$512K
- Samir AhujaMentor$430K
- David SheynCincinnati$330K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.